APA (7th ed.) Citation

Ma, J. D., Nafziger, A. N., Villano, S. A., Gaedigk, A., & Bertino, J. S. (2006). Maribavir Pharmacokinetics and the Effects of Multiple-Dose Maribavir on Cytochrome P450 (CYP) 1A2, CYP 2C9, CYP 2C19, CYP 2D6, CYP 3A, N-Acetyltransferase-2, and Xanthine Oxidase Activities in Healthy Adults. Antimicrobial Agents and Chemotherapy, 50(4), 1130-1135. https://doi.org/10.1128/AAC.50.4.1130-1135.2006

Chicago Style (17th ed.) Citation

Ma, Joseph D., Anne N. Nafziger, Stephen A. Villano, Andrea Gaedigk, and Joseph S. Bertino. "Maribavir Pharmacokinetics and the Effects of Multiple-Dose Maribavir on Cytochrome P450 (CYP) 1A2, CYP 2C9, CYP 2C19, CYP 2D6, CYP 3A, N-Acetyltransferase-2, and Xanthine Oxidase Activities in Healthy Adults." Antimicrobial Agents and Chemotherapy 50, no. 4 (2006): 1130-1135. https://doi.org/10.1128/AAC.50.4.1130-1135.2006.

MLA (9th ed.) Citation

Ma, Joseph D., et al. "Maribavir Pharmacokinetics and the Effects of Multiple-Dose Maribavir on Cytochrome P450 (CYP) 1A2, CYP 2C9, CYP 2C19, CYP 2D6, CYP 3A, N-Acetyltransferase-2, and Xanthine Oxidase Activities in Healthy Adults." Antimicrobial Agents and Chemotherapy, vol. 50, no. 4, 2006, pp. 1130-1135, https://doi.org/10.1128/AAC.50.4.1130-1135.2006.